CompanyCYTKNasdaqSouth San Francisco, CA

Cytokinetics

Cytokinetics develops cardiac myosin modulators for heart disease.

10-KSep 24Latest SEC filing, period to Jun 30

Aug 28Latest story

August 2026

Aug 28Clinical readoutaficamten Cytokinetics

Aug 6Quarterly updateaficamten Cytokinetics